Drug class · Gastrointestinal
5-HT3 receptor antagonists Drug Codes & NDCs
Drugs that block the serotonin-3 receptor, such as ondansetron and granisetron, in oral and injectable forms.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Ondansetron Hydrochloride | Ondansetron hydrochloride 4 mg/1 | Tablet, Film coatedOral | Unit Dose Solutions, Inc. | 87441-064 |
| Ondansetron Hydrochloride | Ondansetron hydrochloride 4 mg/1 | Tablet, Film coatedOral | Unit Dose Solutions, Inc. | 87441-088 |
| Ondansetron ODTondansetron | Ondansetron 4 mg/1 | Tablet, Orally disintegratingOral | Advanced Rx of Tennessee, LLC | 80425-0073 |
| Palonosetron | Palonosetron hydrochloride .05 mg/mL | Injection, SolutionIntravenous | NorthStar Rx LLC | 16714-834 |
| Palonosetron | Palonosetron hydrochloride .05 mg/mL | Injection, SolutionIntravenous | Dr.Reddy's Laboratories Limited | 55111-694 |
| Palonosetronpalonosetron hydrochloride | Palonosetron hydrochloride .25 mg/5mL | InjectionIntravenous | Apotex Corp. | 60505-6193 |
| Palonosetronpalonosetron hydrochloride | Palonosetron hydrochloride .25 mg/5mL | InjectionIntravenous | Apotex Corp. | 60505-6439 |
| Palonosetron | Palonosetron hydrochloride .25 mg/5mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 63323-673 |
| Palonosetronpalonosetron hydrochloride | Palonosetron hydrochloride .25 mg/5mL | InjectionIntravenous | Qilu Pharmaceutical Co., Ltd. | 67184-0514 |
| Palonosetronpalonosetron hydrochloride | Palonosetron hydrochloride .075 mg/1.5mL | InjectionIntravenous | Qilu Pharmaceutical Co., Ltd. | 67184-0515 |
| Palonosetron | Palonosetron hydrochloride .05 mg/mL | Injection, SolutionIntravenous | BluePoint Laboratories | 68001-355 |
| Palonosetronpalonosetron hydrochloride | Palonosetron hydrochloride .25 mg/5mL | InjectionIntravenous | BLuePoint Laboratories | 68001-708 |
| Palonosetron Hydrochloride | Palonosetron hydrochloride .25 mg/5mL | Injection, SolutionIntravenous | Teva Parenteral Medicines, Inc. | 0703-4094 |
| Palonosetron Hydrochloride | Palonosetron hydrochloride .25 mg/5mL | Injection, SolutionIntravenous | Sandoz Inc | 0781-3312 |
| palonosetron hydrochloride | Palonosetron hydrochloride .05 mg/mL | Injection, SolutionIntravenous | Sagent Pharmaceuticals | 25021-783 |
| Palonosetron Hydrochloride | Palonosetron hydrochloride .25 mg/5mL | InjectionIntravenous | Baxter Healthcare Corporation | 36000-326 |
| Palonosetron Hydrochloride | Palonosetron hydrochloride .25 mg/5mL | Injection, SolutionIntravenous | Eugia US LLC | 55150-186 |
| Palonosetron Hydrochloride | Palonosetron hydrochloride .25 mg/5mL | Injection, SolutionIntravenous | Mylan Institutional LLC | 67457-317 |
| palonosetron hydrochloride | Palonosetron hydrochloride .25 mg/5mL | InjectionIntravenous | Cipla USA Inc. | 69097-927 |
| Palonosetron Hydrochloride | Palonosetron hydrochloride .25 mg/5mL | Injection, SolutionIntravenous | Meitheal Pharmaceuticals Inc. | 71288-409 |
| posfreapalonosetron | Palonosetron hydrochloride .25 mg/5mL | Injection, SolutionIntravenous | Avyxa Pharma, LLC | 83831-105 |
| Sancusogranisetron | Granisetron 3.1 mg/24h | PatchTransdermal | Cumberland Pharmaceuticals Inc. | 66220-637 |
| Sustolgranisetron | Granisetron 10 mg/.4mL | InjectionSubcutaneous | Heron Therapeutics, Inc. | 47426-101 |